InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Friday, 06/02/2017 10:49:49 AM

Friday, June 02, 2017 10:49:49 AM

Post# of 48316
"...we really believe that there is a strong potential for an accelerated approval in this nonresponder patient population, of course based on the clinical trials outcome."

This was the best part of the call for me. The "new" FDA seems to really be interested in cutting approval time from what I can tell.